Jacobio Pharmaceuticals Group Co., Ltd. (1167.HK)

HKD 3.14

(1.29%)

Operating Expenses Summary of Jacobio Pharmaceuticals Group Co., Ltd.

Jacobio Pharmaceuticals Group Co., Ltd.'s latest annual operating expenses in 2023 was 401.08 Million CNY , down -15.58% from previous year.
Jacobio Pharmaceuticals Group Co., Ltd.'s latest quarterly operating expenses in 2024 Q1 was 92.94 Million CNY , down -13.18% from previous quarter.
Jacobio Pharmaceuticals Group Co., Ltd. reported a annual operating expenses of 487.36 Million CNY in annual operating expenses 2022, up 54.64% from previous year.
Jacobio Pharmaceuticals Group Co., Ltd. reported a annual operating expenses of 315.15 Million CNY in annual operating expenses 2021, up 35.39% from previous year.
Jacobio Pharmaceuticals Group Co., Ltd. reported a quarterly operating expenses of 92.94 Million CNY for 2024 Q1, down -13.18% from previous quarter.
Jacobio Pharmaceuticals Group Co., Ltd. reported a quarterly operating expenses of 411.43 Million CNY for 2023 FY, down -15.58% from previous quarter.

Annual Operating Expenses Chart of Jacobio Pharmaceuticals Group Co., Ltd. (2023 - 2018)

Historical Annual Operating Expenses of Jacobio Pharmaceuticals Group Co., Ltd. (2023 - 2018)

Year	Operating Expenses	Operating Expenses Growth
2023	401.08 Million CNY	-15.58%
2022	487.36 Million CNY	54.64%
2021	315.15 Million CNY	35.39%
2020	232.78 Million CNY	16.14%
2019	200.43 Million CNY	90.36%
2018	105.29 Million CNY	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	92.94 Million CNY	0.0%
2024 Q1	92.94 Million CNY	-13.18%
2023 FY	411.43 Million CNY	-15.58%
2023 Q2	93.48 Million CNY	0.0%
2023 Q1	93.48 Million CNY	-28.8%
2023 Q4	107.05 Million CNY	0.0%
2023 Q3	107.05 Million CNY	14.52%
2022 Q2	72.12 Million CNY	0.0%
2022 FY	487.36 Million CNY	54.64%
2022 Q4	131.29 Million CNY	0.0%
2022 Q3	131.29 Million CNY	82.04%
2022 Q1	72.12 Million CNY	-21.49%
2021 Q2	74.24 Million CNY	0.0%
2021 Q3	91.86 Million CNY	23.72%
2021 Q4	91.86 Million CNY	0.0%
2021 FY	315.15 Million CNY	35.39%
2021 Q1	74.24 Million CNY	-87.05%
2020 FY	232.78 Million CNY	16.14%
2020 Q4	573.29 Million CNY	0.0%
2020 Q3	573.29 Million CNY	41.18%
2020 Q2	406.05 Million CNY	0.0%
2020 Q1	406.05 Million CNY	198.02%
2019 Q2	78.84 Million CNY	0.0%
2019 Q3	136.25 Million CNY	72.81%
2019 Q4	136.25 Million CNY	0.0%
2019 Q1	78.84 Million CNY	0.0%
2019 FY	200.43 Million CNY	90.36%
2018 FY	105.29 Million CNY	0.0%

Peer Operating Expenses Comparison of Jacobio Pharmaceuticals Group Co., Ltd.

Name	Operating Expenses	Operating Expenses Difference
Uni-Bio Science Group Limited	325.05 Million HKD	-23.391%
CK Life Sciences Int'l., (Holdings) Inc.	739.25 Million HKD	45.745%